C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) G01N 33/543 (2006.01) G01N 33/574 (2006.01) G01N 33/577 (2006.01)
Patent
CA 2125778
2125778 9312258 PCTABS00023 A method for diagnostic and prognostic monitoring of genotoxic changes in tissue arising from oxidative modifications of the genus consisting of the DNA nucleotide bases containing purine or pyrimidine or structurally or metabolically similar surrogates by analyzing the altered bases or surrogates and comparing those results to baseline levels. [See In re Harmisch, 206 USPQ 300 (1980)]. This method is directed towards diagnosing or predicting the occurrence of neoplasia (cancerous growth), assaying the impact of genotoxic effects brought about by exposure to environmental chemicals, and tracking the effects of such modifications over time in response to oxidative repressing agents.
Cytochem Inc.
Gowling Lafleur Henderson Llp
Pacific Northwest Research Foundation
LandOfFree
Dna biomarkers of cancer and genotoxic injury does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dna biomarkers of cancer and genotoxic injury, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dna biomarkers of cancer and genotoxic injury will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1869547